{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:10:18Z","timestamp":1788282618655,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-6606-7-46","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T09:11:03Z","timestamp":1402650663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys"],"prefix":"10.1186","volume":"7","author":[{"given":"Jannet","family":"Kocerha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda S","family":"Prucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony WS","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136: 215-233. 10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"289_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nbd.2011.12.029","volume":"46","author":"NJ Beveridge","year":"2012","unstructured":"Beveridge NJ, Cairns MJ: MicroRNA dysregulation in schizophrenia. Neurobiol Dis. 2012, 46: 263-271. 10.1016\/j.nbd.2011.12.029.","journal-title":"Neurobiol Dis"},{"key":"289_CR3","doi-asserted-by":"publisher","first-page":"14931","DOI":"10.1523\/JNEUROSCI.4280-10.2010","volume":"30","author":"Y Shi","year":"2010","unstructured":"Shi Y, Zhao X, Hsieh J, Wichterle H, Impey S, Banerjee S, Neveu P, Kosik KS: MicroRNA regulation of neural stem cells and neurogenesis. J Neurosci. 2010, 30: 14931-14936. 10.1523\/JNEUROSCI.4280-10.2010.","journal-title":"J Neurosci"},{"key":"289_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1749-8104-5-25","volume":"5","author":"FB Gao","year":"2010","unstructured":"Gao FB: Context-dependent functions of specific microRNAs in neuronal development. Neural Dev. 2010, 5: 25-10.1186\/1749-8104-5-25.","journal-title":"Neural Dev"},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-415795-8.00004-0","volume":"102","author":"R Fiore","year":"2011","unstructured":"Fiore R, Khudayberdiev S, Saba R, Schratt G: MicroRNA function in the nervous system. Prog Mol Biol Transl Sci. 2011, 102: 47-100.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"289_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.conb.2010.04.002","volume":"20","author":"NK Vo","year":"2010","unstructured":"Vo NK, Cambronne XA, Goodman RH: MicroRNA pathways in neural development and plasticity. Curr Opin Neurobiol. 2010, 20: 457-465. 10.1016\/j.conb.2010.04.002.","journal-title":"Curr Opin Neurobiol"},{"key":"289_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrn2739","volume":"11","author":"X Li","year":"2010","unstructured":"Li X, Jin P: Roles of small regulatory RNAs in determining neuronal identity. Nat Rev Neurosci. 2010, 11: 329-338. 10.1038\/nrn2739.","journal-title":"Nat Rev Neurosci"},{"key":"289_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tins.2012.01.004","volume":"35","author":"HI Im","year":"2012","unstructured":"Im HI, Kenny PJ: MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012, 35: 325-334. 10.1016\/j.tins.2012.01.004.","journal-title":"Trends Neurosci"},{"key":"289_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12017-009-8066-1","volume":"11","author":"J Kocerha","year":"2009","unstructured":"Kocerha J, Kauppinen S, Wahlestedt C: microRNAs in CNS disorders. Neuromolecular Med. 2009, 11: 162-172. 10.1007\/s12017-009-8066-1.","journal-title":"Neuromolecular Med"},{"key":"289_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mp.2009.84","volume":"15","author":"NJ Beveridge","year":"2010","unstructured":"Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ: Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry. 2010, 15: 1176-1189. 10.1038\/mp.2009.84.","journal-title":"Mol Psychiatry"},{"key":"289_CR11","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.0805854106","volume":"106","author":"J Kocerha","year":"2009","unstructured":"Kocerha J, Faghihi MA, Lopez-Toledano MA, Huang J, Ramsey AJ, Caron MG, Sales N, Willoughby D, Elmen J, Hansen HF, Orum H, Kauppinen S, Kenny PJ, Wahlestedt C: MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A. 2009, 106: 3507-3512. 10.1073\/pnas.0805854106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"289_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/1471-2164-12-527","volume":"12","author":"J Kocerha","year":"2011","unstructured":"Kocerha J, Kouri N, Baker M, Finch N, DeJesus-Hernandez M, Gonzalez J, Chidamparam K, Josephs KA, Boeve BF, Graff-Radford NR, Crook J, Dickson DW, Rademakers R: Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genomics. 2011, 12: 527-10.1186\/1471-2164-12-527.","journal-title":"BMC Genomics"},{"key":"289_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature09202","volume":"466","author":"JA Hollander","year":"2010","unstructured":"Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ: Striatal microRNA controls cocaine intake through CREB signalling. Nature. 2010, 466: 197-202. 10.1038\/nature09202.","journal-title":"Nature"},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM: MicroRNAs in Parkinson\u2019s disease. Neurobiol Dis. 2012, 46: 279-284. 10.1016\/j.nbd.2011.12.046.","journal-title":"Neurobiol Dis"},{"key":"289_CR15","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B: Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A. 2008, 105: 6415-6420. 10.1073\/pnas.0710263105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"289_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/ncb1104-1048","volume":"6","author":"P Jin","year":"2004","unstructured":"Jin P, Alisch RS, Warren ST: RNA and microRNAs in fragile X mental retardation. Nat Cell Biol. 2004, 6: 1048-1053. 10.1038\/ncb1104-1048.","journal-title":"Nat Cell Biol"},{"key":"289_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fpsyt.2012.00039","volume":"3","author":"N Mellios","year":"2012","unstructured":"Mellios N, Sur M: The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry. 2012, 3: 39-","journal-title":"Front Psychiatry"},{"key":"289_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fgene.2012.00082","volume":"3","author":"AW Chan","year":"2012","unstructured":"Chan AW, Kocerha J: The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders. Front Genet. 2012, 3: 82-","journal-title":"Front Genet"},{"key":"289_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ: Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011, 10: 83-98. 10.1016\/S1474-4422(10)70245-3.","journal-title":"Lancet Neurol"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10048-005-0025-x","volume":"7","author":"B Cajavec","year":"2006","unstructured":"Cajavec B, Herzel H, Bernard S: Death of neuronal clusters contributes to variance of age at onset in Huntington\u2019s disease. Neurogenetics. 2006, 7: 21-25. 10.1007\/s10048-005-0025-x.","journal-title":"Neurogenetics"},{"key":"289_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O: Juvenile Huntington\u2019s disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?. Mech Ageing Dev. 2006, 127: 208-212. 10.1016\/j.mad.2005.09.012.","journal-title":"Mech Ageing Dev"},{"key":"289_CR22","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","volume":"20","author":"PM Gaughwin","year":"2011","unstructured":"Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bjorkqvist M: Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease. Hum Mol Genet. 2011, 20: 2225-2237. 10.1093\/hmg\/ddr111.","journal-title":"Hum Mol Genet"},{"key":"289_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"ST Lee","year":"2011","unstructured":"Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, Park KH, Jung KH, Lee SK, Kim M, Roh JK: Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol. 2011, 227: 172-179. 10.1016\/j.expneurol.2010.10.012.","journal-title":"Exp Neurol"},{"key":"289_CR24","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S, Sumoy L, Ferrer I, Estivill X: A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010, 38: 7219-7235. 10.1093\/nar\/gkq575.","journal-title":"Nucleic Acids Res"},{"key":"289_CR25","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL: The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci. 2008, 28: 14341-14346. 10.1523\/JNEUROSCI.2390-08.2008.","journal-title":"J Neurosci"},{"key":"289_CR26","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R: MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS One. 2013, 8: e54222-10.1371\/journal.pone.0054222.","journal-title":"PLoS One"},{"key":"289_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.12090","volume":"124","author":"C Soldati","year":"2013","unstructured":"Soldati C, Bithell A, Johnston C, Wong KY, Stanton LW, Buckley NJ: Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease. J Neurochem. 2013, 124: 418-430. 10.1111\/jnc.12090.","journal-title":"J Neurochem"},{"key":"289_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1471-4159.2012.07925.x","volume":"123","author":"J Jin","year":"2012","unstructured":"Jin J, Cheng Y, Zhang Y, Wood W, Peng Q, Hutchison E, Mattson MP, Becker KG, Duan W: Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem. 2012, 123: 477-490. 10.1111\/j.1471-4159.2012.07925.x.","journal-title":"J Neurochem"},{"key":"289_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2202-14-88","volume":"14","author":"J Kocerha","year":"2013","unstructured":"Kocerha J, Liu Y, Willoughby D, Chidamparam K, Benito J, Nelson K, Xu Y, Chi T, Engelhardt H, Moran S, Yang SH, Li SH, Li XJ, Larkin K, Neumann A, Banta H, Yang JJ, Chan AW: Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington\u2019s disease monkeys. BMC Neurosci. 2013, 14: 88-10.1186\/1471-2202-14-88.","journal-title":"BMC Neurosci"},{"key":"289_CR30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1089\/scd.2012.0469","volume":"22","author":"K Putkhao","year":"2013","unstructured":"Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW: Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington\u2019s disease. Stem Cells Dev. 2013, 22: 1198-1205. 10.1089\/scd.2012.0469.","journal-title":"Stem Cells Dev"},{"key":"289_CR31","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi MA, Xie Y, Skotte NH, Ehrnhoefer DE, Graham RK, Kim JE, Bissada N, Yang XW, Paganetti P, Friedlander RM, Leavitt BR, Hayden MR: Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet. 2010, 19: 1528-1538. 10.1093\/hmg\/ddq026.","journal-title":"Hum Mol Genet"},{"key":"289_CR32","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1172\/JCI46305","volume":"121","author":"M Sadagurski","year":"2011","unstructured":"Sadagurski M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, Krainc D, White MF: IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest. 2011, 121: 4070-4081. 10.1172\/JCI46305.","journal-title":"J Clin Invest"},{"key":"289_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrn2474","volume":"9","author":"E Cohen","year":"2008","unstructured":"Cohen E, Dillin A: The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci. 2008, 9: 759-767. 10.1038\/nrn2474.","journal-title":"Nat Rev Neurosci"},{"key":"289_CR34","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1096\/fj.09-134965","volume":"23","author":"C Evangelisti","year":"2009","unstructured":"Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, Galardi S, Bue MC, Massalini S, McDowell HP, Messi E, Gulino A, Farace MG, Ciafr\u00e8 SA: MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J. 2009, 23: 4276-4287. 10.1096\/fj.09-134965.","journal-title":"FASEB J"},{"key":"289_CR35","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/onc.2011.380","volume":"31","author":"T Papagiannakopoulos","year":"2012","unstructured":"Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma IM, Kosik KS: Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 2012, 31: 1884-1895. 10.1038\/onc.2011.380.","journal-title":"Oncogene"},{"key":"289_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1244193","volume":"342","author":"CL Tan","year":"2013","unstructured":"Tan CL, Plotkin JL, Veno MT, Von Schimmelmann M, Feinberg P, Mann S, Handler A, Kjems J, Surmeier DJ, O\u2019Carroll D, Greengard P, Schaefer A: MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science. 2013, 342: 1254-1258. 10.1126\/science.1244193.","journal-title":"Science"},{"key":"289_CR37","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/mds.25237","volume":"27","author":"LJ Cloud","year":"2012","unstructured":"Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM: Seizures in juvenile Huntington\u2019s disease: frequency and characterization in a multicenter cohort. Mov Disord. 2012, 27: 1797-1800. 10.1002\/mds.25237.","journal-title":"Mov Disord"},{"key":"289_CR38","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/mds.25663","volume":"28","author":"S Franciosi","year":"2013","unstructured":"Franciosi S, Shim Y, Lau M, Hayden MR, Leavitt BR: A systematic review and meta-analysis of clinical variables used in Huntington disease research. Mov Disord. 2013, 28: 1987-1994. 10.1002\/mds.25663.","journal-title":"Mov Disord"},{"key":"289_CR39","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1073\/pnas.0611625104","volume":"104","author":"I Gantois","year":"2007","unstructured":"Gantois I, Fang K, Jiang L, Babovic D, Lawrence AJ, Ferreri V, Teper Y, Jupp B, Ziebell J, Morganti-Kossmann CM, O'Brien TJ, Nally R, Sch\u00fctz G, Waddington J, Egan GF, Drago J: Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc Natl Acad Sci U S A. 2007, 104: 4182-4187. 10.1073\/pnas.0611625104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"289_CR40","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1038\/cddis.2013.46","volume":"4","author":"YK Adlakha","year":"2013","unstructured":"Adlakha YK, Saini N: miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis. Cell Death Dis. 2013, 4: e542-10.1038\/cddis.2013.46.","journal-title":"Cell Death Dis"},{"key":"289_CR41","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00018-010-0528-y","volume":"68","author":"YK Adlakha","year":"2011","unstructured":"Adlakha YK, Saini N: MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. Cell Mol Life Sci. 2011, 68: 1415-1428. 10.1007\/s00018-010-0528-y.","journal-title":"Cell Mol Life Sci"},{"key":"289_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","volume":"374","author":"S Almeida","year":"2008","unstructured":"Almeida S, Sarmento-Ribeiro AB, Januario C, Rego AC, Oliveira CR: Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington\u2019s disease patients. Biochem Biophys Res Commun. 2008, 374: 599-603. 10.1016\/j.bbrc.2008.07.009.","journal-title":"Biochem Biophys Res Commun"},{"key":"289_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2008.03.062","volume":"438","author":"AV Teles","year":"2008","unstructured":"Teles AV, Rosenstock TR, Okuno CS, Lopes GS, Bertoncini CR, Smaili SS: Increase in bax expression and apoptosis are associated in Huntington\u2019s disease progression. Neurosci Lett. 2008, 438: 59-63. 10.1016\/j.neulet.2008.03.062.","journal-title":"Neurosci Lett"},{"key":"289_CR44","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","volume":"19","author":"D Yang","year":"2010","unstructured":"Yang D, Wang CE, Zhao B, Li W, Ouyang Z, Liu Z, Yang H, Fan P, O\u2019Neill A, Gu W, Yi H, Li S, Lai L, Li XJ: Expression of Huntington\u2019s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet. 2010, 19: 3983-3994. 10.1093\/hmg\/ddq313.","journal-title":"Hum Mol Genet"},{"key":"289_CR45","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1111\/j.1742-4658.2008.06563.x","volume":"275","author":"NP Bhattacharyya","year":"2008","unstructured":"Bhattacharyya NP, Banerjee M, Majumder P: Huntington\u2019s disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription. FEBS J. 2008, 275: 4271-4279. 10.1111\/j.1742-4658.2008.06563.x.","journal-title":"FEBS J"},{"key":"289_CR46","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/cdd.2009.180","volume":"17","author":"M D\u2019Amelio","year":"2010","unstructured":"D\u2019Amelio M, Cavallucci V, Cecconi F: Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010, 17: 1104-1114. 10.1038\/cdd.2009.180.","journal-title":"Cell Death Differ"},{"key":"289_CR47","first-page":"13","volume":"414","author":"S Mazumder","year":"2008","unstructured":"Mazumder S, Plesca D, Almasan A: Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2008, 414: 13-21.","journal-title":"Methods Mol Biol"},{"key":"289_CR48","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/humu.21005","volume":"30","author":"M Muinos-Gimeno","year":"2009","unstructured":"Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, Alonso P, Menchon JM, Gratacos M, Estivill X, Espinosa-Parrilla Y: Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat. 2009, 30: 1062-1071. 10.1002\/humu.21005.","journal-title":"Hum Mutat"},{"key":"289_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2199-11-95","volume":"11","author":"M Guidi","year":"2010","unstructured":"Guidi M, Muinos-Gimeno M, Kagerbauer B, Marti E, Estivill X, Espinosa-Parrilla Y: Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol. 2010, 11: 95-10.1186\/1471-2199-11-95.","journal-title":"BMC Mol Biol"},{"key":"289_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00109-008-0403-6","volume":"87","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Qiang B, Zhao J, Yuan J, Peng X: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med. 2009, 87: 43-51. 10.1007\/s00109-008-0403-6.","journal-title":"J Mol Med"},{"key":"289_CR51","volume-title":"Neurosci Biobehav Rev","author":"LS Nguyen","year":"2013","unstructured":"Nguyen LS, Wilkinson MF, Gecz J: Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev. 2013, doi:10.1016\/j.neubiorev.2013.10.016. [Epub ahead of print]"},{"key":"289_CR52","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.molcel.2011.04.018","volume":"42","author":"IG Bruno","year":"2011","unstructured":"Bruno IG, Karam R, Huang L, Bhardwaj A, Lou CH, Shum EY, Song HW, Corbett MA, Gifford WD, Gecz J, Pfaff SL, Wilkinson MF: Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell. 2011, 42: 500-510. 10.1016\/j.molcel.2011.04.018.","journal-title":"Mol Cell"},{"key":"289_CR53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW: Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature. 2008, 453: 921-924. 10.1038\/nature06975.","journal-title":"Nature"},{"key":"289_CR54","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ: Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease. Hum Mol Genet. 2008, 17: 2738-2751. 10.1093\/hmg\/ddn175.","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-6606-7-46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:22:49Z","timestamp":1630581769000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/1756-6606-7-46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1186\/1756-6606-7-46","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]},"assertion":[{"value":"24 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"46"}}